Systemic α1A-adrenoceptor antagonist inhibits neointimal growth after balloon injury of rat carotid artery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Teeters, John C ^a   Erami, Cauveh ^a   Zhang, Hua ^a   Faber, James E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptor; Smooth muscle cell

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; NORADRENALIN; SILODOSIN;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTERIAL PRESSURE; ARTICLE; BALLOON CATHETER; CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; INTIMA; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

EID: 0037235386     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00658.2002     Document Type: Article

References (40)

1. 1a-adrenoceptor antagonist, tested in a novel rat model. J Pharmacol Exp Ther 29: 81-91, 1999.
2. Bevan JA, Bevan RD, and Duckles SP. Adrenergic regulation of vascular smooth muscle. In: Handbook of Physiology. The Cardiovascular System. Bethesda, MD: Am. Physiol. Soc., 1980, sect. 2, vol. II, chapt. 18, p. 515-566.
3. Broten T, Ransom R, Scott A, Schorn T, Kling P, Payne L, Bock M, Pettibone D, Siegl P, Nagarathnam D, Miao S, Wong WC, Lagu B, Marzabadi MR, Forray C, and Gluchowski C. In vivo pharmacology of SNAP 6991 (L-780,945), an a-la selective adrenergic receptor antagonist (Abstract). FASEB J 13: A142, 1999.
4. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ Res 87: 840-844, 2000.
5. Dao HH, Martens FM, Lariviere R, Yamaguchi N, Cernacek P, de Champlain J, and Moreau P. Transient involvement of endothelin in hypertrophic remodeling of small arteries. J Hypertens 19: 1801-1812, 2001.
6. Dinenno FA, Jones PA, Seals DR, and Tanaka H. Age-associated arterial wall thickening is related to elevations in sympathetic activity in healthy humans. Am J Physiol Heart Circ Physiol 278: H1205-H1210, 2000.
7. 2-adrenoceptors. Eur J Pharmacol 361: 1-15, 1998.
8. 1-adrenoceptor stimulation directly induces growth of the injured vascular wall in vivo. Am J Physiol Heart Circ Physiol 283: H1577-H1587, 2002.
9. Faber JE. Effects of athesin and urethan-chloralose on neurohumoral cardiovascular regulation. Am J Physiol Regul Integr Comp Physiol 256: R757-R765, 1989.
10. Faber JE, Yang N, and Xin X. Expression of α-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298: 441-452, 2001.
11. 1-receptor antagonists urapidil and prazosin inhibit neointima formation in rat carotid artery induced by balloon catheter injury. Basic Res Cardiol 86, Suppl 1: 75-81, 1991.
12. Garcia-Sainz JA, Vazquez-Prado J, and Villalobos-Molina R. Alpha1-adrenoceptors: Subtypes, signaling, and roles in health and disease. Arch Med Res 30: 449-458, 1999.
13. Guimaraes S and Moura D. Vascular adrenoceptors: An update. Pharmacol Rev 53: 319-356, 2001.
14. Head RJ. Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels 28: 173-178, 1991.
15. 1-adrenoceptors on vascular smooth muscle: Correlation with the regulation of contraction. J Pharmacol Exp Ther 290: 452-463, 1999.
16. Jackson CL, Bush RC, and Browyer DE. Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size. Atherosclerosis 69: 115-122, 1988.
17. 1-adrenoceptor blockade on the development of hypertension in the spontaneously hypertensive rat. Eur J Pharmacol 211: 263-268, 1992.
18. Johnson MD, Grignolo A, Kuha CM, and Schanberg SM. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci 33: 169-180, 1983.
19. Julius S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21: 886-893, 1993.
20. Katzung BG (Editor). Basic and Clinical Pharmacology (7th ed.). Norwalk, CT: Appleton & Lange, 1998.
21. Leech CJ and Faber JE. Different α-adrenoceptor subtypes mediate constriction of arterioles and venules. Am J Physiol Heart Circ Physiol 270: H710-H722, 1996.
22. Libby P, Ridker PM, and Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
23. Michel MC, Schafers RF, and Goepel M. Alpha-blockers and lower urinary tract function: More than smooth muscle relaxation? BJU Int 86, Suppl 2: 23-28, 2000.
24. O'Malley MK, McDermott EW, Mehigan D, and O'Higgins NJ. Role for prazosin in reducing the development of rabbit intimal hyperplasia after endothelial denudation. Br J Surg 76: 936-938, 1989.
25. Piascik MT and Perez DM. Alpha1-adrenergic receptors: New insights and directions. J Pharmacol Exp Ther 298: 403-410, 2001.
26. Piascik MT, Soltis EE, Piascik MM, and Macmillan LB. Alpha-adrenoceptors and vascular regulation: Molecular, pharmacologic and clinical correlates. Pharmacol Ther 72: 215-241, 1996.
27. Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, Long CS, and Simpson PC. Alphal-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of α1B and α1D but induction of α1C. J Biol Chem 271: 5839-5843, 1996.
28. Saito Y and Berk BC. Angiotensin II-mediated signal transduction pathways. Curr Hypertens Rep 4: 167-171, 2002.
29. 1-adrenoceptor subtypes in rat renal resistance vessels: in vivo and in vitro studies. Am J Physiol Renal Physiol 278: F138-F147, 2000.
30. 1-adrenoceptor subtypes on rat afferent arterioles assessed by radioligand binding and RT-PCR. Am J Physiol Renal Physiol 281: F172-F178, 2001.
31. Schwartz SM, deBlois D, and O'Brien ERM. The intima: Soil for atherosclerosis and restenosis. Circ Res 77: 445-465, 1995.
32. Scott A, Broten P, Siegl P, Bock MG, DiPardo R, Payne L, Patane M, Selnick H, Chiu G, Wetzel J, Marzabadi MR, Bluchowski C, and Forray C. Hypotensive potency of α-1 adrenoceptor antagonists in spontaneously hypertensive rats correlates with binding affinity for the α-1d receptor subtype (Abstract).FASEB J 13: A141, 1999.
33. 1-adrenoceptor subtypes: Functions and signaling. Can J Physiol Pharmacol 78: 267-292, 2000.
34. Vashisht R, Sian M, Franks PJ, and O'Malley MK. Long-term reduction of intimal hyperplasia by the selective al adrenergic antagonist doxazosin. Br J Surg 79: 1285-1288, 1992.
35. Ward MR, Pasterkamp G, Yeung AC, and Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 102: 1186-1191, 2000.
36. Xin X, Yang N, Eckhart AD, Faber JE. α1D-adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol Pharmacol 51: 764-775, 1997.
37. 1A-adrenoreceptor subtype selectivity of KMD-3213 in rat tissues. J Pharmacol Exp Ther 296: 160-167, 2001.
38. Zhang H, Facemire CS, Banes AJ, and Faber JE. Norepinephrine stimulates migration of vascular smooth muscle cells and adventitial fibroblasts in vitro: Mediation by different adrenoceptor subtypes. Am J Physiol Heart Circ Physiol 282: H2364-H2370, 2002.
39. Zhang H and Faber JE. Trophic effect of norepinephrine on arterial intima-media and adventitia is augmented by injury and mediated by different α1-adrenoceptor subtypes. Circ Res 89: 815-822, 2001.
40. Zhang H, Thomas SA, Cotecchia S, Tsujimoto G, and Faber JE. Gene knockouts for dopamine β-hydroxylase (DBH), α1B- and α1D-adrenoceptors (AR) support participation of α1-AR-mediated trophic action in vascular hypertrophic outward remodeling following carotid injury (Abstract). FASEB J 16: A215, 2002.